ClinicalTrials.Veeva

Menu

STEpwise Research Program to Promote INGeniouS ONline Supportive Solutions in the Relief of Cancer-related Fatigue (STEPPING-STONe)

G

Gustave Roussy

Status

Not yet enrolling

Conditions

Cancer Diagnosis
Moderate or Severe Score of Cancer-related Fatigue (CRF)

Treatments

Device: Educational content
Device: Educational material plus self-management program - guided version with mental health professional
Device: Educational material plus self-management program - self-administered version

Study type

Interventional

Funder types

Other

Identifiers

NCT06505590
2023-A02082-43
2023/3717 (Other Identifier)

Details and patient eligibility

About

Decentralized, randomized hybrid type 2 (effectiveness/implementation) controlled trial comparing the effectiveness of three different digital aid modalities programs in reducing the perceived burden of CRF in cancer patients while also gathering data on the implementation strategy.

Enrollment

372 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 years and older.
  • Having a clinical diagnosis of cancer including patients on active treatment or cancer survivors.
  • Self-reporting moderate to severe CRF for at least one week (worst level of fatigue ≥ 4 on a 10-point numerical rating scale, retained in international guidelines as an optimal cutoff for identifying clinically significant CRF).
  • Being able to read and understand French.
  • Having access to a smartphone.
  • Patients must be affiliated to a social security system or beneficiary of the same.

Exclusion criteria

  • Suffering from current psychiatric disorder or cognitive disorder that would interfere with the ability to consent or participate.
  • Currently engaging in cognitive-behavioral therapy.
  • Currently engaging in another non-drug (behavioral) clinical trial.
  • Suffering from physical related reversible and treatable causes of fatigue (anemia, electrolytes unbalance, infections, renal dysfunction, active metastases causing fatigue, hormonal unbalances (hypothyroidism, adrenal insufficiency, etc.) - according to physician's judgement at the moment of inclusion.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

372 participants in 3 patient groups

Educational material aid tool
Sham Comparator group
Description:
Educational content on the mobile app Resilience © in the format of articles, videos or podcasts on treatment related symptoms and on validated supportive care interventions.
Treatment:
Device: Educational content
Educational material plus self-management program - self-administered version
Experimental group
Description:
Mobile app (Resilience ©) with its educational content plus a self-guided fatigue self-management program based on a cognitive behavioral therapy approach.
Treatment:
Device: Educational material plus self-management program - self-administered version
Educational material plus self-management program - guided version with mental health professional
Experimental group
Description:
Mobile app (Resilience ©) with its educational content and the self-management program of arm 2 plus weekly calls with a certified mental health professional certified in cognitive behavioural therapy for guided coaching across the self-management program.
Treatment:
Device: Educational material plus self-management program - guided version with mental health professional

Trial contacts and locations

1

Loading...

Central trial contact

Ines VAZ-LUIS, MD; Maria Alice FRAZOI, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems